(1) The RECIPIENT shall obtain a prior agreement from the DEVELOPER Dr. Hiroyasu Esumi (National Cancer Center)(hesumi@east.ncc.go.jp ) to transfer the BIOLOGICAL RESOURCE. (2) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the Acc.No. CDB0555K and Web Site (www2.clst.riken.jp/arg/mutant%20mice%20list.html) is requested. (3) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the literature designed by the DEPOSITOR is requested (J Biol Chem. 2012 287(20):16379-89.). (4) Please inform the DEPOSITOR (mutant.bdr@riken.jp) about the paper when published. D (more than 6 months) RBRC09347 Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> 条件を付加する。<br>(1) 分与希望者は事前に開発者 江角 浩安(国立がんセンター)(hesumi@east.ncc.go.jp )に連絡をとり、分与に関して許可を得ること。(2)当該マウスを用いる論文発表に際してはAcc.No. CDB0555K、そのWEBサイト(www2.clst.riken.jp/arg/mutant%20mice%20list.html)とともに当該マウスを記載すること。(3)当該マウスを用いる論文発表に際しては、その由来として第一報論文 (J Biol Chem. 2012 287(20):16379-89.) を引用すること。(4)発表論文を寄託者 (mutant.bdr@riken.jp) に連絡すること。 Ark5 Ark5 マウス Ark5, Neo(大腸菌由来), loxP(P1ファージ由来), frt(酵母由来), PGKプロモーター, PGK3’end/マウス Nuak1(Acc.No.CDB0555K) Nuak1(Acc.No.CDB0555K) D(6か月以上) FLP/frt system true Cre/loxP system RIKEN CDB RIKEN CDB